[makomk]

It's a biologic. There are huge obstacles to licensing generic versions of those in the US, they're quite expensive to produce, and there's a substantial risk that the original manufacturer will drop the price to the point that the generic manufacturer can't make their money back or even incentivise customers not to buy generics: https://www.reuters.com/article/us-merck-co-britain-remicade... In the UK, which is the country that Wikipedia article is about, generics do somewhat work to drive prices down.